Dung T. Le - Researcher Profile | RDL Research Database

Publications

2 shown

Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial

Kei Muro , Hyun Cheol Chung , Veena Shankaran +15 more

2016 The Lancet Oncology 1096 citations

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency

Dung T. Le , Jennifer N. Uram , Hao Wang +32 more

This study showed that mismatch-repair status predicted clinical benefit of immune checkpoint blockade with pembrolizumab. (Funded by Johns Hopkins University and others; Clinic...

2015 New England Journal of Medicine 9106 citations

Frequent Co-Authors

Researcher Info

h-index: 2
Publications: 2
Citations: 10,202
Institution: Johns Hopkins University

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0002-2110-7697

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.